BBVA:BMEBanco Bilbao Vizcaya Argentaria, S.A. Analysis

BBVA currently trades at $21.57, below its 20‑day SMA of 22.99 and 50‑day SMA of 23.82, indicating short‑term weakness, but remains above the 200‑day SMA of 19.70, suggesting longer‑term resilience. The RSI of 38.7 points to modest downside momentum without being oversold, while a negative MACD histogram confirms a bearish tilt in the near term. Support sits at €20.51 and resistance at €24.69, defining a clear trading range. Despite this technical backdrop, the company posted a record net profit for 2025, beating expectations, and added 11.5 million new customers, underpinning earnings momentum.
Valuation metrics show the stock is materially undervalued – the DCF‑derived fair value of €25.04 implies roughly a 12.6 % upside, and the trailing P/E of 10.57 is well below the industry average of 17.38. A dividend yield of 5.06 % with a 41 % payout ratio and strong cash generation supports the dividend’s sustainability. The balance sheet is robust, with cash nearly matching debt, and ROE of 18 % signals efficient capital use. Combined with a stable volume trend and a beta of 0.84, BBVA presents a compelling value‑oriented opportunity amid a sector characterized by moderate risk.